CSIMarket
 
Harvard Bioscience Inc   (NASDAQ: HBIO)
 
Price: $8.1100 $0.18 2.270%
Day's High: $8.11400032043457 Week Perf: 6.99 %
Day's Low: $ 7.92 30 Day Perf: 32.95 %
Volume (M): 32,324 52 Wk High: $ 9.40
Volume (M$): $ 0 52 Wk Avg: $5.85
Open: $7.92 52 Wk Low: $3.80



 Market Capitalization (Millions $) 36
 Shares Outstanding (Millions) 4
 Employees 339
 Revenues (TTM) (Millions $) 85
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 2

Business Description


Harvard Bioscience Inc.
is a global company that provides a wide range of products and services for the research, discovery, and clinical markets.
The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Harvard Bioscience is primarily focused on three major business units: Life Science Research, Clinical and Research Diagnostics, and Pre-clinical Services.
Life Science Research segment offers a range of products, including precision syringe pumps, laboratory software, manual and automated cell culture and electroporation systems, motorized and manual microdissection systems, and general laboratory equipment.
Clinical and Research Diagnostics segment provides instruments, reagents, and software for clinical and research applications in pathology, immunology, and microbiology.
Pre-Clinical Services segment provides contract research services to pharmaceutical and biotechnology companies, supporting preclinical drug development (including regulated safety pharmacology and toxicology services), vascular and cardiac research, and biocompatibility testing to assess device safety.
Harvard Bioscience provides the products and services to academic and government research institutions, pharmaceutical and biotechnology companies, and contract research organizations across the globe.
The company is focused on advancing life sciences research and providing innovative solutions to address the challenges faced by biopharma companies in drug discovery and development.
Its mission is to accelerate advancements in life sciences and to bring cutting-edge technology and services to its customers.


   Company Address: 84 October Hill Road Holliston 1746 MA
   Company Phone Number: 893-8999   Stock Exchange / Ticker: NASDAQ HBIO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
A        0.08% 
AVTR        1.96% 
BIO        1.14% 
BRKR        1.81% 
CTKB        7.66% 
MTD        0.45% 
• View Complete Report
   



Product Service News

Harvard Bioscience Unveils Groundbreaking Solutions for Preclinical and Organoid Applications, Paving the Way for Unprecedented Research Efficiency and Data Analytics Advancements.

Published Wed, Mar 6 2024 1:30 PM UTC

Harvard Bioscience to Showcase Cutting-Edge Solutions for Preclinical Advancements and Organoid Applications, Revolutionizing Research Efficiency and Data Analytics in CROs, Pharma, and BiotechsBoston, MA - March 12, 2021Harvard Bioscience, a world-renowned provider of innovative solutions for life science research, is set to unveil its latest breakthrough technologies and a...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.43
Price to Sales (Expected) -
Price to Book 3.61
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.35
Working Capital Ratio 2.35
Leverage Ratio (MRQ) 6.76
Total Debt to Equity 3.6
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.21 $
Revenues (TTM) 19 $
Cash Flow (TTM) 0.35 $
Cash 1.59 $
Book Value 2.25 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 250,649
Net Income per Employee (TTM) -28,861
Receivable Turnover Ratio (TTM) 6.22
Inventory Turnover Ratio (TTM) 1.61
Asset Turnover Ratio (TTM) 1.08

Profitability Ratios Current
Gross Margin (MRQ) 60.48 %
Operating Margin (MRQ) -5.8 %
Net Margin (MRQ) -16.91 %
Net Cash Flow Margin (MRQ) -7.49 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Harvard Bioscience Inc's Segments
Transferred at Point in Time    96 % of total Revenue
Transferred over Time    6.52 % of total Revenue
Instruments Equipment Software and Accessories    91.71 % of total Revenue
Service Maintenance and Warranty Contracts    10.22 % of total Revenue
UNITED STATES    43.49 % of total Revenue
Americas Other    4.18 % of total Revenue
EMEA    31.97 % of total Revenue
CHINA    13.87 % of total Revenue
Asia Other    9.02 % of total Revenue
Installation and Training    4.34 % of total Revenue
Customer Advances    3.56 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.